Search

everythinglearnresearchcommunity

for

Search:↓

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

HST and HST/F promote hair growth and may help treat alopecia.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Testosterone therapy increases bone density in older men with low testosterone levels.

The study found that in Latin America, ancestry varies by location, influences physical traits, and affects how people perceive their own heritage.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

The method can effectively extract biomedical information without needing expert annotation, performing better than previous models.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

More dermal papilla cells in hair follicles lead to larger, healthier hair, while fewer cells cause hair thinning and loss.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Lactate production is important for activating hair growth stem cells.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Finasteride for hair loss can cause long-lasting sexual side effects like low libido and erectile dysfunction.

Researchers created human hair follicles using a new method that could help treat hair loss.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.